Increased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasma.
Cells of the myeloid lineage are significant targets for human immunodeficiency virus (HIV) in humans and simian immunodeficiency virus (SIV) in monkeys. Monocytes play critical roles in innate and adaptive immunity during inflammation. We hypothesize that specific subsets of monocytes expand with AIDS and drive central nervous system (CNS) disease. Additionally, there may be expansion of cells from the bone marrow through blood with subsequent macrophage accumulation in tissues driving pathogenesis. To identify monocytes that recently emigrated from bone marrow, we used 5-bromo-2'-deoxyuridine (BrdU) labeling in a longitudinal study of SIV-infected CD8+ T lymphocyte depleted macaques. Monocyte expansion and kinetics in blood was assessed and newly migrated monocyte/macrophages were identified within the CNS. Five animals developed rapid AIDS with differing severity of SIVE. The percentages of BrdU+ monocytes in these animals increased dramatically, early after infection, peaking at necropsy where the percentage of BrdU+ monocytes correlated with the severity of SIVE. Early analysis revealed changes in the percentages of BrdU+ monocytes between slow and rapid progressors as early as 8 days and consistently by 27 days post infection. Soluble CD163 (sCD163) in plasma correlated with the percentage of BrdU+ monocytes in blood, demonstrating a relationship between monocyte activation and expansion with disease. BrdU+ monocytes/macrophages were found within perivascular spaces and SIVE lesions. The majority (80-90%) of the BrdU+ cells were Mac387+ that were not productively infected. There was a minor population of CD68+BrdU+ cells (<10%), very few of which were infected (<1% of total BrdU+ cells). Our results suggest that an increased rate of monocyte recruitment from bone marrow into the blood correlates with rapid progression to AIDS, and the magnitude of BrdU+ monocytes correlates with the severity of SIVE.
Burdo
Tricia H
TH
Biology Department, Boston College, Chestnut Hill, Massachusetts, United States of America.
Soulas
Caroline
C
Orzechowski
Krystyna
K
Button
Jessica
J
Krishnan
Anitha
A
Sugimoto
Chie
C
Alvarez
Xavier
X
Kuroda
Marcelo J
MJ
Williams
Kenneth C
KC
D000818:Animals; D015703:Antigens, CD / Q000097:blood / Q000276:immunology; D015214:Antigens, Differentiation, Myelomonocytic / Q000097:blood / Q000276:immunology; D001854:Bone Marrow Cells / Q000276:immunology; D002469:Cell Separation; D018792:Encephalitis, Viral / Q000209:etiology / Q000276:immunology* / Q000473:pathology; D004797:Enzyme-Linked Immunosorbent Assay; D005434:Flow Cytometry; D007150:Immunohistochemistry; D008251:Macaca; D018613:Microscopy, Confocal; D009000:Monocytes / Q000276:immunology*; D011956:Receptors, Cell Surface / Q000097:blood / Q000276:immunology; D016097:Simian Acquired Immunodeficiency Syndrome / Q000150:complications / Q000276:immunology* / Q000473:pathology*; D015302:Simian Immunodeficiency Virus; D019562:Viral Load; D000098902:CD163 Antigen
D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D000098902:CD163 Antigen; D011956:Receptors, Cell Surface